nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—NR3C1—glaucoma	0.525	1	CbGaD
Podofilox—CYP2C19—Methazolamide—glaucoma	0.0439	0.205	CbGbCtD
Podofilox—CYP2C19—Timolol—glaucoma	0.0374	0.174	CbGbCtD
Podofilox—CYP3A4—Pilocarpine—glaucoma	0.0314	0.146	CbGbCtD
Podofilox—CYP3A4—Brinzolamide—glaucoma	0.0247	0.115	CbGbCtD
Podofilox—CYP3A4—Dorzolamide—glaucoma	0.0238	0.111	CbGbCtD
Podofilox—CYP3A4—Methazolamide—glaucoma	0.0212	0.0989	CbGbCtD
Podofilox—CYP3A4—Acetazolamide—glaucoma	0.017	0.0791	CbGbCtD
Podofilox—CYP3A4—Clonidine—glaucoma	0.0154	0.0715	CbGbCtD
Podofilox—Scab—Latanoprost—glaucoma	0.00631	0.0343	CcSEcCtD
Podofilox—Skin burning sensation—Brimonidine—glaucoma	0.00564	0.0307	CcSEcCtD
Podofilox—Redness—Echothiophate—glaucoma	0.00546	0.0297	CcSEcCtD
Podofilox—Stinging—Dipivefrin—glaucoma	0.00543	0.0295	CcSEcCtD
Podofilox—Scab—Apraclonidine—glaucoma	0.00505	0.0274	CcSEcCtD
Podofilox—Stinging—Echothiophate—glaucoma	0.00455	0.0247	CcSEcCtD
Podofilox—Scab—Brimonidine—glaucoma	0.00433	0.0236	CcSEcCtD
Podofilox—Scab—Dorzolamide—glaucoma	0.00414	0.0225	CcSEcCtD
Podofilox—Scab—Travoprost—glaucoma	0.00412	0.0224	CcSEcCtD
Podofilox—Scab—Brinzolamide—glaucoma	0.00407	0.0221	CcSEcCtD
Podofilox—Etoposide—GSTT1—glaucoma	0.00365	0.8	CrCbGaD
Podofilox—Excoriation—Clonidine—glaucoma	0.00329	0.0179	CcSEcCtD
Podofilox—Instillation site pain—Clonidine—glaucoma	0.00305	0.0166	CcSEcCtD
Podofilox—Stinging—Carbachol—glaucoma	0.00271	0.0148	CcSEcCtD
Podofilox—Stinging—Levobunolol—glaucoma	0.00267	0.0145	CcSEcCtD
Podofilox—Tingling sensation—Methazolamide—glaucoma	0.00258	0.014	CcSEcCtD
Podofilox—Tenderness—Carbachol—glaucoma	0.00252	0.0137	CcSEcCtD
Podofilox—Stinging—Latanoprost—glaucoma	0.00248	0.0135	CcSEcCtD
Podofilox—Ulcer—Carbachol—glaucoma	0.00232	0.0126	CcSEcCtD
Podofilox—TUBA4A—Loss of Nlp from mitotic centrosomes—FGFR1OP—glaucoma	0.00227	0.0328	CbGpPWpGaD
Podofilox—Application site pain—Clonidine—glaucoma	0.00226	0.0123	CcSEcCtD
Podofilox—Scab—Timolol—glaucoma	0.00222	0.0121	CcSEcCtD
Podofilox—Inflammation—Latanoprost—glaucoma	0.00207	0.0113	CcSEcCtD
Podofilox—TUBA4A—Centrosome maturation—FGFR1OP—glaucoma	0.00201	0.0291	CbGpPWpGaD
Podofilox—Redness—Dorzolamide—glaucoma	0.00195	0.0106	CcSEcCtD
Podofilox—TUBB—Loss of Nlp from mitotic centrosomes—FGFR1OP—glaucoma	0.00193	0.0279	CbGpPWpGaD
Podofilox—Stinging—Bimatoprost—glaucoma	0.00192	0.0104	CcSEcCtD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00185	0.0267	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00181	0.0262	CbGpPWpGaD
Podofilox—Tingling sensation—Acetazolamide—glaucoma	0.00179	0.00971	CcSEcCtD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.00174	0.0251	CbGpPWpGaD
Podofilox—Skin discolouration—Bimatoprost—glaucoma	0.00172	0.00937	CcSEcCtD
Podofilox—TUBB—Centrosome maturation—FGFR1OP—glaucoma	0.00171	0.0247	CbGpPWpGaD
Podofilox—Stinging—Brimonidine—glaucoma	0.0017	0.00925	CcSEcCtD
Podofilox—Inflammation—Apraclonidine—glaucoma	0.00165	0.009	CcSEcCtD
Podofilox—Stinging—Dorzolamide—glaucoma	0.00162	0.00883	CcSEcCtD
Podofilox—Erythema—Echothiophate—glaucoma	0.00161	0.00876	CcSEcCtD
Podofilox—Inflammation—Bimatoprost—glaucoma	0.0016	0.00872	CcSEcCtD
Podofilox—Skin ulcer—Pilocarpine—glaucoma	0.0016	0.00868	CcSEcCtD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00157	0.0227	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00154	0.0223	CbGpPWpGaD
Podofilox—Stinging—Pilocarpine—glaucoma	0.00154	0.00834	CcSEcCtD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.00151	0.0218	CbGpPWpGaD
Podofilox—Tenderness—Travoprost—glaucoma	0.0015	0.00816	CcSEcCtD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.00148	0.0213	CbGpPWpGaD
Podofilox—TOP2A—Alprenolol—Metipranolol—glaucoma	0.00146	0.588	CbGdCrCtD
Podofilox—Skin discolouration—Travoprost—glaucoma	0.00145	0.00789	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—ATOH7—glaucoma	0.00141	0.0203	CbGpPWpGaD
Podofilox—TUBA4A—G2/M Transition—FGFR1OP—glaucoma	0.00139	0.0201	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.00137	0.0198	CbGpPWpGaD
Podofilox—Inflammation—Travoprost—glaucoma	0.00135	0.00734	CcSEcCtD
Podofilox—Pain—Dipivefrin—glaucoma	0.00134	0.0073	CcSEcCtD
Podofilox—TUBA4A—G2/M Transition—RAB8A—glaucoma	0.0013	0.0189	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00129	0.0186	CbGpPWpGaD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.00128	0.0185	CbGpPWpGaD
Podofilox—Skin ulcer—Clonidine—glaucoma	0.00128	0.00693	CcSEcCtD
Podofilox—TUBB—G2/M Transition—FGFR1OP—glaucoma	0.00118	0.017	CbGpPWpGaD
Podofilox—Vomiting—Physostigmine—glaucoma	0.00117	0.00638	CcSEcCtD
Podofilox—TUBB—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.00116	0.0168	CbGpPWpGaD
Podofilox—Swelling—Brimonidine—glaucoma	0.00113	0.00616	CcSEcCtD
Podofilox—TUBA4A—G2/M Transition—OPTN—glaucoma	0.00113	0.0163	CbGpPWpGaD
Podofilox—Pain—Echothiophate—glaucoma	0.00113	0.00612	CcSEcCtD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—OPTN—glaucoma	0.00111	0.0161	CbGpPWpGaD
Podofilox—TUBB—G2/M Transition—RAB8A—glaucoma	0.00111	0.016	CbGpPWpGaD
Podofilox—Haematuria—Methazolamide—glaucoma	0.00111	0.00601	CcSEcCtD
Podofilox—TUBB—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00109	0.0158	CbGpPWpGaD
Podofilox—Dry skin—Bimatoprost—glaucoma	0.00104	0.00563	CcSEcCtD
Podofilox—TOP2A—Alprenolol—Betaxolol—glaucoma	0.00102	0.412	CbGdCrCtD
Podofilox—TUBB—G2/M Transition—OPTN—glaucoma	0.000961	0.0139	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—OPTN—glaucoma	0.000948	0.0137	CbGpPWpGaD
Podofilox—Dermatitis bullous—Pilocarpine—glaucoma	0.000945	0.00513	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000944	0.0136	CbGpPWpGaD
Podofilox—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000921	0.0133	CbGpPWpGaD
Podofilox—Dry skin—Brimonidine—glaucoma	0.000917	0.00498	CcSEcCtD
Podofilox—Etoposide—PTGS2—glaucoma	0.000911	0.2	CrCbGaD
Podofilox—Inflammation—Betaxolol—glaucoma	0.000891	0.00485	CcSEcCtD
Podofilox—Oedema—Metipranolol—glaucoma	0.000882	0.0048	CcSEcCtD
Podofilox—Erythema—Latanoprost—glaucoma	0.000878	0.00477	CcSEcCtD
Podofilox—Stinging—Timolol—glaucoma	0.000872	0.00474	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—TGFB2—glaucoma	0.000856	0.0124	CbGpPWpGaD
Podofilox—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000839	0.0121	CbGpPWpGaD
Podofilox—Dry skin—Pilocarpine—glaucoma	0.000827	0.0045	CcSEcCtD
Podofilox—Oedema—Carteolol—glaucoma	0.000818	0.00444	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000815	0.0118	CbGpPWpGaD
Podofilox—Haemorrhage—Apraclonidine—glaucoma	0.000806	0.00438	CcSEcCtD
Podofilox—Haematuria—Acetazolamide—glaucoma	0.000766	0.00416	CcSEcCtD
Podofilox—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.000754	0.0109	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.000742	0.00403	CcSEcCtD
Podofilox—Insomnia—Carteolol—glaucoma	0.000739	0.00402	CcSEcCtD
Podofilox—Paraesthesia—Diclofenamide—glaucoma	0.000722	0.00392	CcSEcCtD
Podofilox—Oedema—Latanoprost—glaucoma	0.000716	0.00389	CcSEcCtD
Podofilox—Erythema—Apraclonidine—glaucoma	0.000702	0.00381	CcSEcCtD
Podofilox—Skin disorder—Latanoprost—glaucoma	0.000696	0.00378	CcSEcCtD
Podofilox—Paraesthesia—Levobunolol—glaucoma	0.000694	0.00377	CcSEcCtD
Podofilox—Erythema—Bimatoprost—glaucoma	0.00068	0.0037	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00068	0.00983	CbGpPWpGaD
Podofilox—Pain—Carbachol—glaucoma	0.000671	0.00365	CcSEcCtD
Podofilox—Paraesthesia—Methazolamide—glaucoma	0.000665	0.00361	CcSEcCtD
Podofilox—Haematuria—Pilocarpine—glaucoma	0.000663	0.00361	CcSEcCtD
Podofilox—Pain—Levobunolol—glaucoma	0.000661	0.00359	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—SOD1—glaucoma	0.000649	0.00938	CbGpPWpGaD
Podofilox—Immune system disorder—Brimonidine—glaucoma	0.000625	0.0034	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000618	0.00893	CbGpPWpGaD
Podofilox—Pain—Latanoprost—glaucoma	0.000613	0.00333	CcSEcCtD
Podofilox—Erythema—Brimonidine—glaucoma	0.000602	0.00327	CcSEcCtD
Podofilox—Immune system disorder—Travoprost—glaucoma	0.000594	0.00323	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000593	0.00323	CcSEcCtD
Podofilox—Immune system disorder—Brinzolamide—glaucoma	0.000587	0.00319	CcSEcCtD
Podofilox—Dizziness—Metipranolol—glaucoma	0.000584	0.00317	CcSEcCtD
Podofilox—Erythema—Dorzolamide—glaucoma	0.000575	0.00313	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000575	0.00313	CcSEcCtD
Podofilox—Erythema—Travoprost—glaucoma	0.000573	0.00311	CcSEcCtD
Podofilox—Oedema—Apraclonidine—glaucoma	0.000573	0.00311	CcSEcCtD
Podofilox—Pruritus—Diclofenamide—glaucoma	0.000569	0.00309	CcSEcCtD
Podofilox—Erythema—Brinzolamide—glaucoma	0.000566	0.00307	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—OPN4—glaucoma	0.00056	0.00809	CbGpPWpGaD
Podofilox—Rash—Metipranolol—glaucoma	0.000556	0.00302	CcSEcCtD
Podofilox—Skin disorder—Apraclonidine—glaucoma	0.000556	0.00302	CcSEcCtD
Podofilox—Dermatitis—Metipranolol—glaucoma	0.000556	0.00302	CcSEcCtD
Podofilox—Headache—Metipranolol—glaucoma	0.000553	0.00301	CcSEcCtD
Podofilox—Pruritus—Levobunolol—glaucoma	0.000547	0.00297	CcSEcCtD
Podofilox—Dizziness—Carteolol—glaucoma	0.000541	0.00294	CcSEcCtD
Podofilox—Skin disorder—Bimatoprost—glaucoma	0.000539	0.00293	CcSEcCtD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IL1A—glaucoma	0.000533	0.0077	CbGpPWpGaD
Podofilox—Dizziness—Diclofenamide—glaucoma	0.000532	0.00289	CcSEcCtD
Podofilox—Dizziness—Carbachol—glaucoma	0.000519	0.00282	CcSEcCtD
Podofilox—Insomnia—Apraclonidine—glaucoma	0.000518	0.00282	CcSEcCtD
Podofilox—Paraesthesia—Apraclonidine—glaucoma	0.000514	0.0028	CcSEcCtD
Podofilox—Headache—Carteolol—glaucoma	0.000512	0.00278	CcSEcCtD
Podofilox—Vomiting—Diclofenamide—glaucoma	0.000511	0.00278	CcSEcCtD
Podofilox—Dizziness—Levobunolol—glaucoma	0.000511	0.00278	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—DHPS—glaucoma	0.00051	0.00738	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000509	0.00277	CcSEcCtD
Podofilox—Pruritus—Latanoprost—glaucoma	0.000507	0.00276	CcSEcCtD
Podofilox—Rash—Diclofenamide—glaucoma	0.000507	0.00275	CcSEcCtD
Podofilox—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000504	0.00729	CbGpPWpGaD
Podofilox—Headache—Diclofenamide—glaucoma	0.000504	0.00274	CcSEcCtD
Podofilox—Insomnia—Bimatoprost—glaucoma	0.000502	0.00273	CcSEcCtD
Podofilox—Vomiting—Carbachol—glaucoma	0.000499	0.00271	CcSEcCtD
Podofilox—Rash—Carbachol—glaucoma	0.000495	0.00269	CcSEcCtD
Podofilox—Dermatitis—Carbachol—glaucoma	0.000494	0.00269	CcSEcCtD
Podofilox—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000493	0.00713	CbGpPWpGaD
Podofilox—Oedema—Brimonidine—glaucoma	0.000492	0.00267	CcSEcCtD
Podofilox—Headache—Carbachol—glaucoma	0.000491	0.00267	CcSEcCtD
Podofilox—Pain—Apraclonidine—glaucoma	0.00049	0.00266	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000484	0.00263	CcSEcCtD
Podofilox—Headache—Levobunolol—glaucoma	0.000484	0.00263	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000478	0.0026	CcSEcCtD
Podofilox—Skin disorder—Brimonidine—glaucoma	0.000478	0.0026	CcSEcCtD
Podofilox—Pain—Bimatoprost—glaucoma	0.000475	0.00258	CcSEcCtD
Podofilox—Dizziness—Latanoprost—glaucoma	0.000474	0.00258	CcSEcCtD
Podofilox—Vomiting—Methazolamide—glaucoma	0.000471	0.00256	CcSEcCtD
Podofilox—Oedema—Dorzolamide—glaucoma	0.00047	0.00255	CcSEcCtD
Podofilox—Oedema—Travoprost—glaucoma	0.000468	0.00254	CcSEcCtD
Podofilox—Rash—Methazolamide—glaucoma	0.000467	0.00254	CcSEcCtD
Podofilox—Dermatitis—Methazolamide—glaucoma	0.000466	0.00253	CcSEcCtD
Podofilox—Headache—Methazolamide—glaucoma	0.000464	0.00252	CcSEcCtD
Podofilox—Paraesthesia—Acetazolamide—glaucoma	0.00046	0.0025	CcSEcCtD
Podofilox—Skin disorder—Travoprost—glaucoma	0.000454	0.00247	CcSEcCtD
Podofilox—Rash—Latanoprost—glaucoma	0.000452	0.00246	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—FN1—glaucoma	0.000451	0.00653	CbGpPWpGaD
Podofilox—Dermatitis—Latanoprost—glaucoma	0.000451	0.00245	CcSEcCtD
Podofilox—Headache—Latanoprost—glaucoma	0.000449	0.00244	CcSEcCtD
Podofilox—Skin disorder—Brinzolamide—glaucoma	0.000448	0.00244	CcSEcCtD
Podofilox—Insomnia—Brimonidine—glaucoma	0.000445	0.00242	CcSEcCtD
Podofilox—Oedema—Pilocarpine—glaucoma	0.000444	0.00241	CcSEcCtD
Podofilox—Paraesthesia—Brimonidine—glaucoma	0.000441	0.0024	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000441	0.00638	CbGpPWpGaD
Podofilox—Erythema—Clonidine—glaucoma	0.000434	0.00236	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.00043	0.00622	CbGpPWpGaD
Podofilox—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000426	0.00615	CbGpPWpGaD
Podofilox—Insomnia—Dorzolamide—glaucoma	0.000425	0.00231	CcSEcCtD
Podofilox—Paraesthesia—Dorzolamide—glaucoma	0.000422	0.00229	CcSEcCtD
Podofilox—Pain—Brimonidine—glaucoma	0.00042	0.00229	CcSEcCtD
Podofilox—Insomnia—Brinzolamide—glaucoma	0.000418	0.00227	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000415	0.006	CbGpPWpGaD
Podofilox—Paraesthesia—Brinzolamide—glaucoma	0.000415	0.00225	CcSEcCtD
Podofilox—Pruritus—Apraclonidine—glaucoma	0.000405	0.0022	CcSEcCtD
Podofilox—Pain—Dorzolamide—glaucoma	0.000402	0.00218	CcSEcCtD
Podofilox—Insomnia—Pilocarpine—glaucoma	0.000401	0.00218	CcSEcCtD
Podofilox—Pain—Travoprost—glaucoma	0.0004	0.00217	CcSEcCtD
Podofilox—Paraesthesia—Pilocarpine—glaucoma	0.000398	0.00217	CcSEcCtD
Podofilox—Pain—Brinzolamide—glaucoma	0.000395	0.00215	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—FGFR1OP—glaucoma	0.000394	0.0057	CbGpPWpGaD
Podofilox—Pruritus—Bimatoprost—glaucoma	0.000393	0.00214	CcSEcCtD
Podofilox—Immune system disorder—Betaxolol—glaucoma	0.000392	0.00213	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.00038	0.00549	CbGpPWpGaD
Podofilox—Pain—Pilocarpine—glaucoma	0.000379	0.00206	CcSEcCtD
Podofilox—Dizziness—Apraclonidine—glaucoma	0.000379	0.00206	CcSEcCtD
Podofilox—Erythema—Betaxolol—glaucoma	0.000378	0.00205	CcSEcCtD
Podofilox—TUBB—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000375	0.00542	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—RAB8A—glaucoma	0.000371	0.00536	CbGpPWpGaD
Podofilox—Dizziness—Bimatoprost—glaucoma	0.000367	0.002	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000367	0.002	CcSEcCtD
Podofilox—Vomiting—Apraclonidine—glaucoma	0.000364	0.00198	CcSEcCtD
Podofilox—Dermatitis—Apraclonidine—glaucoma	0.000361	0.00196	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—OPTN—glaucoma	0.00036	0.0052	CbGpPWpGaD
Podofilox—Headache—Apraclonidine—glaucoma	0.000359	0.00195	CcSEcCtD
Podofilox—Oedema—Clonidine—glaucoma	0.000354	0.00193	CcSEcCtD
Podofilox—TUBB—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000353	0.0051	CbGpPWpGaD
Podofilox—Rash—Bimatoprost—glaucoma	0.00035	0.0019	CcSEcCtD
Podofilox—Dermatitis—Bimatoprost—glaucoma	0.00035	0.0019	CcSEcCtD
Podofilox—Pruritus—Brimonidine—glaucoma	0.000348	0.00189	CcSEcCtD
Podofilox—Headache—Bimatoprost—glaucoma	0.000348	0.00189	CcSEcCtD
Podofilox—Skin disorder—Clonidine—glaucoma	0.000344	0.00187	CcSEcCtD
Podofilox—Dizziness—Acetazolamide—glaucoma	0.000339	0.00184	CcSEcCtD
Podofilox—TUBB—Cell Cycle—FGFR1OP—glaucoma	0.000335	0.00485	CbGpPWpGaD
Podofilox—Pruritus—Dorzolamide—glaucoma	0.000332	0.00181	CcSEcCtD
Podofilox—Pruritus—Travoprost—glaucoma	0.000331	0.0018	CcSEcCtD
Podofilox—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000329	0.00475	CbGpPWpGaD
Podofilox—Pruritus—Brinzolamide—glaucoma	0.000327	0.00178	CcSEcCtD
Podofilox—Vomiting—Acetazolamide—glaucoma	0.000326	0.00177	CcSEcCtD
Podofilox—Dizziness—Brimonidine—glaucoma	0.000325	0.00177	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—OPTN—glaucoma	0.000322	0.00465	CbGpPWpGaD
Podofilox—Headache—Acetazolamide—glaucoma	0.000321	0.00174	CcSEcCtD
Podofilox—Insomnia—Clonidine—glaucoma	0.00032	0.00174	CcSEcCtD
Podofilox—Immune system disorder—Timolol—glaucoma	0.00032	0.00174	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00032	0.00174	CcSEcCtD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.000319	0.00462	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTSA—glaucoma	0.000318	0.0046	CbGpPWpGaD
Podofilox—Paraesthesia—Clonidine—glaucoma	0.000318	0.00173	CcSEcCtD
Podofilox—TUBB—Cell Cycle—RAB8A—glaucoma	0.000315	0.00456	CbGpPWpGaD
Podofilox—Pruritus—Pilocarpine—glaucoma	0.000314	0.00171	CcSEcCtD
Podofilox—Dizziness—Dorzolamide—glaucoma	0.000311	0.00169	CcSEcCtD
Podofilox—Rash—Brimonidine—glaucoma	0.00031	0.00169	CcSEcCtD
Podofilox—Dermatitis—Brimonidine—glaucoma	0.00031	0.00168	CcSEcCtD
Podofilox—Dizziness—Travoprost—glaucoma	0.000309	0.00168	CcSEcCtD
Podofilox—Erythema—Timolol—glaucoma	0.000309	0.00168	CcSEcCtD
Podofilox—Oedema—Betaxolol—glaucoma	0.000308	0.00168	CcSEcCtD
Podofilox—Headache—Brimonidine—glaucoma	0.000308	0.00167	CcSEcCtD
Podofilox—TUBB—Cell Cycle, Mitotic—OPTN—glaucoma	0.000306	0.00442	CbGpPWpGaD
Podofilox—Dizziness—Brinzolamide—glaucoma	0.000305	0.00166	CcSEcCtD
Podofilox—Pain—Clonidine—glaucoma	0.000303	0.00165	CcSEcCtD
Podofilox—Skin disorder—Betaxolol—glaucoma	0.0003	0.00163	CcSEcCtD
Podofilox—Vomiting—Dorzolamide—glaucoma	0.000299	0.00162	CcSEcCtD
Podofilox—Rash—Dorzolamide—glaucoma	0.000296	0.00161	CcSEcCtD
Podofilox—Dermatitis—Dorzolamide—glaucoma	0.000296	0.00161	CcSEcCtD
Podofilox—Rash—Travoprost—glaucoma	0.000295	0.0016	CcSEcCtD
Podofilox—Dermatitis—Travoprost—glaucoma	0.000295	0.0016	CcSEcCtD
Podofilox—Headache—Dorzolamide—glaucoma	0.000294	0.0016	CcSEcCtD
Podofilox—Vomiting—Brinzolamide—glaucoma	0.000294	0.0016	CcSEcCtD
Podofilox—Dizziness—Pilocarpine—glaucoma	0.000293	0.00159	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—ACE2—glaucoma	0.000293	0.00424	CbGpPWpGaD
Podofilox—Headache—Travoprost—glaucoma	0.000293	0.00159	CcSEcCtD
Podofilox—Rash—Brinzolamide—glaucoma	0.000291	0.00158	CcSEcCtD
Podofilox—Dermatitis—Brinzolamide—glaucoma	0.000291	0.00158	CcSEcCtD
Podofilox—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.00029	0.00419	CbGpPWpGaD
Podofilox—Headache—Brinzolamide—glaucoma	0.000289	0.00157	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000288	0.00416	CbGpPWpGaD
Podofilox—Vomiting—Pilocarpine—glaucoma	0.000282	0.00153	CcSEcCtD
Podofilox—Rash—Pilocarpine—glaucoma	0.00028	0.00152	CcSEcCtD
Podofilox—Dermatitis—Pilocarpine—glaucoma	0.000279	0.00152	CcSEcCtD
Podofilox—Insomnia—Betaxolol—glaucoma	0.000279	0.00152	CcSEcCtD
Podofilox—Headache—Pilocarpine—glaucoma	0.000278	0.00151	CcSEcCtD
Podofilox—Paraesthesia—Betaxolol—glaucoma	0.000277	0.00151	CcSEcCtD
Podofilox—TUBB—Cell Cycle—OPTN—glaucoma	0.000273	0.00395	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000268	0.00387	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000266	0.00384	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000265	0.00383	CbGpPWpGaD
Podofilox—Pain—Betaxolol—glaucoma	0.000264	0.00143	CcSEcCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000262	0.00379	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000261	0.00142	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—glaucoma	0.000258	0.00374	CbGpPWpGaD
Podofilox—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000256	0.0037	CbGpPWpGaD
Podofilox—Oedema—Timolol—glaucoma	0.000252	0.00137	CcSEcCtD
Podofilox—Pruritus—Clonidine—glaucoma	0.000251	0.00136	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—glaucoma	0.000248	0.00358	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000247	0.00357	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.000246	0.00356	CbGpPWpGaD
Podofilox—Skin disorder—Timolol—glaucoma	0.000245	0.00133	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000244	0.00352	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.00024	0.00347	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	0.000239	0.00345	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—FGFR1OP—glaucoma	0.000235	0.00339	CbGpPWpGaD
Podofilox—Dizziness—Clonidine—glaucoma	0.000234	0.00127	CcSEcCtD
Podofilox—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000232	0.00335	CbGpPWpGaD
Podofilox—Insomnia—Timolol—glaucoma	0.000228	0.00124	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000227	0.00328	CbGpPWpGaD
Podofilox—Paraesthesia—Timolol—glaucoma	0.000226	0.00123	CcSEcCtD
Podofilox—Vomiting—Clonidine—glaucoma	0.000225	0.00122	CcSEcCtD
Podofilox—Rash—Clonidine—glaucoma	0.000223	0.00121	CcSEcCtD
Podofilox—Dermatitis—Clonidine—glaucoma	0.000223	0.00121	CcSEcCtD
Podofilox—Headache—Clonidine—glaucoma	0.000222	0.00121	CcSEcCtD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000221	0.0032	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RAB8A—glaucoma	0.000221	0.00319	CbGpPWpGaD
Podofilox—Pruritus—Betaxolol—glaucoma	0.000218	0.00119	CcSEcCtD
Podofilox—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000216	0.00313	CbGpPWpGaD
Podofilox—Pain—Timolol—glaucoma	0.000216	0.00117	CcSEcCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000214	0.00309	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000213	0.00307	CbGpPWpGaD
Podofilox—Dizziness—Betaxolol—glaucoma	0.000204	0.00111	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	0.000201	0.0029	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—FN1—glaucoma	0.0002	0.0029	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—NGFR—glaucoma	0.000199	0.00288	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000197	0.00285	CbGpPWpGaD
Podofilox—Vomiting—Betaxolol—glaucoma	0.000196	0.00107	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—TGFB2—glaucoma	0.000196	0.00283	CbGpPWpGaD
Podofilox—Rash—Betaxolol—glaucoma	0.000194	0.00106	CcSEcCtD
Podofilox—Dermatitis—Betaxolol—glaucoma	0.000194	0.00106	CcSEcCtD
Podofilox—Headache—Betaxolol—glaucoma	0.000193	0.00105	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—OPTN—glaucoma	0.000191	0.00276	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—NTRK1—glaucoma	0.000189	0.00274	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000184	0.00266	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000182	0.00263	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000181	0.00262	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000181	0.00261	CbGpPWpGaD
Podofilox—Pruritus—Timolol—glaucoma	0.000178	0.000969	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.000177	0.00256	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000174	0.00252	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000174	0.00252	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000173	0.0025	CbGpPWpGaD
Podofilox—Dizziness—Timolol—glaucoma	0.000167	0.000906	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND2—glaucoma	0.000165	0.00239	CbGpPWpGaD
Podofilox—Vomiting—Timolol—glaucoma	0.00016	0.000871	CcSEcCtD
Podofilox—Rash—Timolol—glaucoma	0.000159	0.000864	CcSEcCtD
Podofilox—Dermatitis—Timolol—glaucoma	0.000159	0.000863	CcSEcCtD
Podofilox—Headache—Timolol—glaucoma	0.000158	0.000858	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—PAX6—glaucoma	0.000156	0.00226	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000155	0.00224	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000149	0.00215	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—FAS—glaucoma	0.000148	0.00215	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SOD1—glaucoma	0.000148	0.00214	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000148	0.00214	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND2—glaucoma	0.000148	0.00213	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000142	0.00206	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND2—glaucoma	0.00014	0.00203	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000137	0.00198	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000137	0.00198	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2B—glaucoma	0.000132	0.00191	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000132	0.00191	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00013	0.00188	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—FAS—glaucoma	0.000129	0.00186	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000126	0.00182	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000126	0.00182	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND2—glaucoma	0.000126	0.00182	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000125	0.00181	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000122	0.00176	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	0.000117	0.00169	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000116	0.00167	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000115	0.00166	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MMP1—glaucoma	0.000113	0.00164	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2B—glaucoma	0.000113	0.00163	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000111	0.0016	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000109	0.00158	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000109	0.00157	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CAV1—glaucoma	0.000108	0.00157	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—FN1—glaucoma	0.000103	0.00149	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTT1—glaucoma	9.93e-05	0.00144	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND2—glaucoma	9.82e-05	0.00142	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	9.72e-05	0.00141	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	9.59e-05	0.00139	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	9.21e-05	0.00133	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.96e-05	0.0013	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP1—glaucoma	8.9e-05	0.00129	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2B—glaucoma	8.8e-05	0.00127	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND2—glaucoma	8.78e-05	0.00127	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—glaucoma	8.47e-05	0.00122	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS3—glaucoma	8.2e-05	0.00119	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—glaucoma	7.92e-05	0.00114	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1B1—glaucoma	7.92e-05	0.00114	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2B—glaucoma	7.87e-05	0.00114	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	7.81e-05	0.00113	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	7.66e-05	0.00111	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—glaucoma	7.57e-05	0.00109	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1B—glaucoma	7.5e-05	0.00108	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.39e-05	0.00107	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—glaucoma	7.2e-05	0.00104	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	6.98e-05	0.00101	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA5A—glaucoma	6.96e-05	0.00101	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NARFL—glaucoma	6.96e-05	0.00101	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—glaucoma	6.89e-05	0.000995	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1B—glaucoma	6.7e-05	0.000969	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	6.56e-05	0.000949	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—glaucoma	6.44e-05	0.00093	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1B—glaucoma	6.37e-05	0.000922	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—glaucoma	6.33e-05	0.000915	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	6.24e-05	0.000902	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.97e-05	0.000864	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—glaucoma	5.91e-05	0.000854	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.79e-05	0.000837	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1B—glaucoma	5.7e-05	0.000824	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—glaucoma	5.56e-05	0.000803	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	5.54e-05	0.0008	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.52e-05	0.000798	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—glaucoma	5.47e-05	0.000791	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	5.03e-05	0.000728	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.76e-05	0.000688	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	4.73e-05	0.000684	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.69e-05	0.000679	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—glaucoma	4.5e-05	0.000651	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—glaucoma	4.46e-05	0.000645	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	4.46e-05	0.000645	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—glaucoma	4.21e-05	0.000609	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NARFL—glaucoma	4.19e-05	0.000605	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA5A—glaucoma	4.19e-05	0.000605	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—glaucoma	3.99e-05	0.000576	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.81e-05	0.00055	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.75e-05	0.000543	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—glaucoma	3.58e-05	0.000518	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA1—glaucoma	3.4e-05	0.000492	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CTSA—glaucoma	3.29e-05	0.000476	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA2—glaucoma	3.11e-05	0.00045	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.04e-05	0.000439	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.04e-05	0.000439	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CDKN2B—glaucoma	2.67e-05	0.000385	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—glaucoma	2.51e-05	0.000362	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TXN—glaucoma	2.19e-05	0.000317	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA1—glaucoma	2.04e-05	0.000296	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	2e-05	0.000289	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.98e-05	0.000286	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CTSA—glaucoma	1.98e-05	0.000286	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA2—glaucoma	1.87e-05	0.00027	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—glaucoma	1.7e-05	0.000246	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.37e-05	0.000198	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCA1—glaucoma	1.35e-05	0.000196	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1B1—glaucoma	1.35e-05	0.000196	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TXN—glaucoma	1.32e-05	0.00019	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—glaucoma	1.08e-05	0.000156	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—glaucoma	1.02e-05	0.000148	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—glaucoma	9.56e-06	0.000138	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—glaucoma	8.9e-06	0.000129	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAV1—glaucoma	8.82e-06	0.000128	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCA1—glaucoma	8.14e-06	0.000118	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1B1—glaucoma	8.14e-06	0.000118	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NOS3—glaucoma	6.67e-06	9.64e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—glaucoma	6.51e-06	9.41e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—glaucoma	6.1e-06	8.82e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—glaucoma	5.75e-06	8.31e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—glaucoma	5.35e-06	7.74e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAV1—glaucoma	5.3e-06	7.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NOS3—glaucoma	4.01e-06	5.8e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—glaucoma	3.67e-06	5.3e-05	CbGpPWpGaD
